2024
DOI: 10.2174/0113816128277350231219062154
|View full text |Cite
|
Sign up to set email alerts
|

Differential Signaling Pathways in Medulloblastoma: Nano-biomedicine Targeting Non-coding Epigenetics to Improve Current and Future Therapeutics

Daniil Sokolov,
Neha Sharda,
Aindrila Banerjee
et al.

Abstract: Background: Medulloblastomas (MDB) are malignant, aggressive brain tumors that primarily affect children. The survival rate for children under 14 is approximately 72%, while for ages 15 to 39, it is around 78%. A growing body of evidence suggests that dysregulation of signaling mechanisms and noncoding RNA epigenetics play a pivotal role in this disease. Methodology: This study conducted an electronic search of articles on websites like PubMed and Google. The current review also used an in silico databases s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2024
2024
2025
2025

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 8 publications
references
References 142 publications
0
0
0
Order By: Relevance